Donor Milk

OTHER4 trials

Sponsors

NICHD Neonatal Research Network, Laura Kair, University of California, San Francisco, Carmen Rosa Pallas

Conditions

Breast Milk Substitute IntoleranceBreastfeedingBreastfeeding DurationDonor Milk SupplementationExclusive BreastfeedingGrowth DelayInfant, Extremely Low Birth WeightInfant, Newborn

Phase 3

Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants

CompletedNCT01534481

NICHD Neonatal Research NetworkInfant, Extremely Low Birth Weight, Infant, Newborn, Infant, Small for Gestational Age

Start: 2012-08-31End: 2021-11-30Updated: 2023-02-06

Unknown Phase

Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes

CompletedNCT02221167

Laura KairBreastfeeding Duration, Donor Milk Supplementation, Exclusive Breastfeeding

Start: 2014-07-31End: 2016-09-30Updated: 2018-03-16

The Milk, Growth and Microbiota Study

SuspendedNCT03220282

University of California, San FranciscoBreastfeeding, Breast Milk Substitute Intolerance, Growth Delay +2

Start: 2017-10-30End: 2026-01-31Target: 48Updated: 2025-04-24

Clinical Impact of Donor Milk Pasteurized by HTST Treatment in Preterm Infants

CompletedNCT04424667

Carmen Rosa PallasLate-Onset Neonatal Sepsis

Start: 2020-06-15End: 2023-09-15Updated: 2023-09-22

Related Papers

Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula

JAMA2024-01-3053 citations